Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bergamaschini

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Immunology|April 8, 1999
Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent mannerL Bergamaschini, S Canziani, B Bottasso, et al.
Alzheimer Disease and Associated Disorders|July 3, 1998
Activation of the contact system in cerebrospinal fluid of patients with Alzheimer diseaseL Bergamaschini, L Parnetti, D Pareyson, et al.
The American Journal of the Medical Sciences|July 1, 1982
Hereditary angioedema: an appraisal of 104 casesM Cicardi, L Bergamaschini, B Marasini, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|July 1, 1994
Antiproteasic activity of C1 inhibitor. Therapeutic perspectivesM Cicardi, P Testoni, L Bergamaschini, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1995
Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factorL Bergamaschini, P M Mannucci, A B Federici, et al.
Clinical and Experimental Immunology|May 26, 1999
Consumption of C4b-binding protein (C4BP) during in vivo activation of the classical complement pathwayL Bergamaschini, A Miedico, M Cicardi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1996
Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexesL Bergamaschini, T Santangelo, A Faricciotti, et al.
Allergy|February 1, 1983
C1 INH concentrate in the therapy of hereditary angioedemaL Bergamaschini, M Cicardi, A Tucci, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1983
Complement activation in adult respiratory distress syndrome treated with long-term extracorporeal CO2 removalA Agostoni, M Cicardi, L Bergamaschini, et al.
The International Journal of Artificial Organs|May 1, 1985
Studies of complement activation in ARDS patients treated by long-term extracorporeal CO2 removalM Gardinali, M Cicardi, D Frangi, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|April 8, 1999
Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent mannerL Bergamaschini, S Canziani, B Bottasso, et al.
Alzheimer Disease and Associated Disorders|July 3, 1998
Activation of the contact system in cerebrospinal fluid of patients with Alzheimer diseaseL Bergamaschini, L Parnetti, D Pareyson, et al.
The American Journal of the Medical Sciences|July 1, 1982
Hereditary angioedema: an appraisal of 104 casesM Cicardi, L Bergamaschini, B Marasini, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|July 1, 1994
Antiproteasic activity of C1 inhibitor. Therapeutic perspectivesM Cicardi, P Testoni, L Bergamaschini, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1995
Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factorL Bergamaschini, P M Mannucci, A B Federici, et al.
Clinical and Experimental Immunology|May 26, 1999
Consumption of C4b-binding protein (C4BP) during in vivo activation of the classical complement pathwayL Bergamaschini, A Miedico, M Cicardi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1996
Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexesL Bergamaschini, T Santangelo, A Faricciotti, et al.
Allergy|February 1, 1983
C1 INH concentrate in the therapy of hereditary angioedemaL Bergamaschini, M Cicardi, A Tucci, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1983
Complement activation in adult respiratory distress syndrome treated with long-term extracorporeal CO2 removalA Agostoni, M Cicardi, L Bergamaschini, et al.
The International Journal of Artificial Organs|May 1, 1985
Studies of complement activation in ARDS patients treated by long-term extracorporeal CO2 removalM Gardinali, M Cicardi, D Frangi, et al.
Pageof 5